Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Thomas McMaster"'
Autor:
Katelyn R. Einloth, Scott Gayfield, Thomas McMaster, Alexander Didier, Lance Dworkin, Justin Fortune Creeden
Publikováno v:
BioImpacts, Vol 13, Iss 6, Pp 439-455 (2023)
Introduction: Immunotherapy has revolutionized how cancer is treated. Many of these immunotherapies rely on ex vivo expansion of immune cells, classically T cells. Still, several immunological obstacles remain, including tumor impermeability by immun
Externí odkaz:
https://doaj.org/article/108cbecef2d7450cb6830151afab2483
Publikováno v:
EBioMedicine, Vol 51, Iss , Pp - (2020)
Background: Half of muscle-invasive bladder cancer patients will relapse with metastatic disease and molecular tests to predict relapse are needed. TP63 has been proposed as a prognostic biomarker in bladder cancer, but reports associating it with cl
Externí odkaz:
https://doaj.org/article/c8425c70d14b410ab9193715ae8a848e
Publikováno v:
Telemedicine and e-Health. 29:50-59
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44947a22089f2a0ba4adce706aba8a06
https://doi.org/10.1089/tmj.2021.0409
https://doi.org/10.1089/tmj.2021.0409
Publikováno v:
Annals of Medicine and Surgery
Introduction Telemedicine has emerged as a powerful tool in the delivery of healthcare to surgical patients and enhances clinician-patient encounters during all phases of patient care. Our study aims were: to review the current use and applicability
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efc302e6b4c1ea190126301783cfed19
https://pubmed.ncbi.nlm.nih.gov/33996071
https://pubmed.ncbi.nlm.nih.gov/33996071
Publikováno v:
EBioMedicine
EBioMedicine, Vol 51, Iss, Pp-(2020)
EBioMedicine, Vol 51, Iss, Pp-(2020)
Background: Half of muscle-invasive bladder cancer patients will relapse with metastatic disease and molecular tests to predict relapse are needed. TP63 has been proposed as a prognostic biomarker in bladder cancer, but reports associating it with cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caa5fa5dd58d349cec91e6977c440494
https://pubmed.ncbi.nlm.nih.gov/31927310
https://pubmed.ncbi.nlm.nih.gov/31927310
Publikováno v:
Clinical Cancer Research. 26:B02-B02
Bladder cancer will cause an estimated 17,000 deaths this year in the United States. Transformation-related protein 63 (TP63) is a p53 family transcription factor that has been shown to be important for development and is commonly expressed in bladde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce93b4e668a864205fdfd91ae4cbdac4
https://doi.org/10.1158/1557-3265.bladder19-b02
https://doi.org/10.1158/1557-3265.bladder19-b02
